ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Clinical trials for ENDOMETRIAL UNDIFFERENTIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL UNDIFFERENTIATED CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL UNDIFFERENTIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two drugs vs. one: new hope for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is for people whose endometrial (uterine) cancer has returned after treatment. It compares two different immunotherapy approaches to see which is better at controlling the cancer. One group gets a single immunotherapy drug (nivolumab), while the other gets a combinatio…
Matched conditions: ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Breakthrough trial aims to outsmart aggressive uterine cancer
Disease control Recruiting nowThis study is testing if adding newer, faster-to-administer targeted drugs to standard chemotherapy works better for people with a specific type of advanced uterine cancer (HER2-positive). It will involve 360 participants who have not had prior chemotherapy. The main goal is to s…
Matched conditions: ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC